|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Primary cervical cancer screening with human papillomavirus:End of study results from the ATHENA study using HPV as the first-line screening test显示文摘 | Wright TC Stoler MH Behrens CM | 2015 | Gynecol Oncol2015，136，2： | 1 |
| 2 | The ATHENA hu- man papillomavirus study: design, methods, and baseline results 显示文摘 | Wright TC Jr Stoler MH Behrens CM | 2012 | Am J Obstet Gynecol2012，206，1： | 1 |
| 3 | A common biological mechanism in cancer and Alzheimer's disease? 显示文摘 | Behrens MI Lendon C Roe CM | 2009 | Curr Alzheimer Res2009，6，3： | 1 |
| 4 | The ATHENA human papillomavirus study: design, methods, and baseline results显示文摘 | Wright Jr TC Stoler MH Behrens CM | 2012 | AmJ Obstet Gynecol2012，206，1： | 1 |
| 5 | The CD8 alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens显示文摘 | Belz GT Behrens GM Smith CM | 2002 | J Exp Med2002，196，8： | 1 |
| 6 | Primaq' cervical cancer screening with human papillomavirus:end of study results from the ATHENA study using HPV as the first-line screening test 显示文摘 | Wright TC Stoler MH Behrens CM | 2015 | Gynecol Onco12015，136，2： | 1 |
| 7 | The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens显示文摘 | Belz GT Behrens GMN Smith CM | 2002 | J Exp Med2002，196，8： | 1 |
| 8 | The CD8a + dendritic cell is responsible for inducing peripheral self-tolerance to tissue- associated antigens显示文摘 | Belz GT Behrens GMN Smith CM | 2002 | J Exp Med2002，196，8： | 1 |
| 9 | Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test 显示文摘 | Wright TC Stoler MH Behrens CM | 2015 | Gynecol Oncol2015，136，2： | 1 |
| 10 | Helper T cells,dendritic cells and CTL Immunity显示文摘 | Behrens G Li M Smith CM | 2004 | immunol Cell Biol2004，82，1： | 1 |
| 11 | The CD8alpha( + ) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens 显示文摘 | Belz GT Behrens GM Smith CM | 2002 | J Exp Med2002，196，8： | 1 |
| 12 | Primary cervical cancer screening with human papillomavirus:end of study results from the ATHENA study using HPV as the first-line screening test显示文摘 | Wright TC Stoler MH Behrens CM | 2015 | Gynecol Oncol2015，136，2： | 1 |
| 13 | Primary cervical cancer screening with human papillomavirus : end of study results from the ATHENA study using HPV as the first-line screening test 显示文摘 | Wright TC Stoler MH Behrens CM | 2015 | Gynecol Oncol2015，136，2： | 1 |
| 14 | Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing,and genotyping for HPV 16/18 :results from the ATHE-NA HPV study 显示文摘 | Cox JT Castle PE Behrens CM | 2013 | Am J Obstet Gynecol2013，208，184： | 1 |
| 15 | Interlaboratory variation in the performance of liquid-based cytology: in- sights from the ATHENA trial 显示文摘 | Wright TC Stoler MH Behrens CM | 2014 | Int J Cancer2014，134，8： | 1 |
| 16 | Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing,and genotyping for HPV 16/18:resuhs from the A- THENA HPV study显示文摘 | Cox JT Castle PE Behrens CM | 2013 | Am J Obstet Gyneco12013，208，3： | 1 |
| 17 | Interlaboratory variation in the performance of liquid-based cytology:insights from the Athena trial显示文摘 | Wright TC Stoler MH Behrens CM | 2014 | Int J Cancer2014，134，8： | 1 |
| 18 | Performance of carcinogenic human pa- pillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervi- cal cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study显示文摘 | WRIGHT L BEHRENS CM | 2011 | The Lancet Oncol2011，12，9： | 1 |
| 19 | Helper T cells, dendritic cells and CTL immunity 显示文摘 | Behrens G Li M Smith CM | 2004 | Immunol Cell Biol2004，82，1： | 1 |
| 20 | Helper T cells,dendritic cells and CTL Immunity显示文摘 | Behrens G Li M Smith CM | 2004 | Immunol Cell Biol2004，82，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员